Zofran Lawsuit Information Center
Women who gave birth to a child with a cleft lip, palate, or another defect may be eligible to file a Zofran lawsuit that alleges its manufacturer’s failure to properly warn about this and other complications of the anti-nausea medication.
Zofran (Ondansetron) or Zuplenz were originally approved in 1991 as a treatment for patients undergoing surgery or cancer treatments such as chemotherapy and radiation, but is often prescribed off-label to treat morning sickness in women. The drug has been associated with the risk for serious birth defects, however, when women take it during pregnancy, especially in the first trimester. This is the infant’s most crucial stage of development.
The attorneys at Bernstein Liebhard LLP advise anyone who may be considering a claim against the medication’s manufacturer, GlaxoSmithKline to file an individual complaint instead of a Zofran class action lawsuit. In a class action case, damage rewards are often distributed evenly among a large group of individuals, regardless of their alleged degree of suffering, or the monies they spent in out-of-pocket medical costs, or lost in wages when they had to call out of work for Zofran-related injuries. Individual lawsuits are instead judged on injuries sustained by a single plaintiff, and receive damage awards that are based off their issues alone. Particularly in the case for Zofran injuries, an individual claim is more beneficial, as side effects of the drug may range in severity from plaintiff to plaintiff.
A History Of The Anti-Nausea Drug Zofran
Zofran is known in its generic form as ondansetron, was first marketed by GlaxoSmithKline in 1991. The first generic brands became available in 2006. It can be administered in the form of a tablet or liquid, or through an injection. Zofran (Ondansetron) and Zuplenz belong to a class of medications that affect the central nervous system and are referred to as 5-HT3 antagonists.
Known side effects of Zofran include diarrhea and constipation, a tired feeling or drowsiness and a headache. A rash or hives, fiver or chills, difficulty breathing and swelling in the face, lips tongue or throat may also follow use of the medication, and may be signs of an allergic reaction.
But other side effects of the medication are far more serious. Individuals who may be eligible to file Zofran birth defect lawsuits gave birth to children with the following issues:
Studies Explore Zofran Pregnancy Issues
The potential link between Zofran and birth defects has been explored in a number of studies conducted in the U.S. and abroad. In August 2013, researchers reported a two-fold increase in cardiovascular defects born to children whose mothers took Zofran during their first trimester of pregnancy. The research was published in Montreal at a meeting of the International Society of Pharmacoepidemiology, and revealed that 4.7 percent of individuals who took the drug at the beginning stage of their pregnancy bore children with congenital abnormalities, as opposed to 3.5 percent who did not taken the medication. Overall, the study’s authors concluded that women taking Zofran, or ondansetron, were 30 percent more likely to have a child with birth defects.
The study looked at 900,000 pregnant women over a 13-year period, and analyzed data from a patient registry in Denmark.
That previous February, research published in The New England Journal of Medicine found little association between Zofran and the risk for birth defects, but it should be noted that it looked at fewer patients (2,000), over a shorter period time (seven years).
Consider a Zofran Birth Defect Lawsuit
Contact an attorney at our Firm for more information about filing a Zofran birth defects lawsuit. You may be entitled to compensation for lost wages, out-of-pocket medical expenses and other costs this medication has caused you and your family. Call us now at .